Single Ascending Dose Trial in Patients With Type 2 Diabetes

Status:
Terminated

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether AMG 876 is safe and well tolerated in subjects with type 2 diabetes.

Phase 1

Amgen